By API User
Melbourne, Australia: BTC Health (ASX: BTC) (BTC or the Company) is pleased to announce the appointment of Salesh Balak as Chief Financial Officer and Company Secretary, effective 17 March 2025. This appointment reflects the underlying expansion of the BTC business, and the appointment of Josh Kahanovitz, current Head of Finance, into the role of Chief Operating Officer from … Continued
By API User
• License and distribution agreement for Bronchitol and Aridol converted from an initial 10- year term to an indefinite license • BTC to earn royalties from sales of Bronchitol and Aridol in Singapore and Malaysia • BTC granted first right of refusal to Arna Pharma’s new product pipeline Melbourne, Australia: BTC Health (ASX: BTC) (BTC or the … Continued
By API User
10 February 2025 – Sydney, Australia | BlinkLab Limited (ASX:BB1) (“BlinkLab” or “the Company”), an innovative digital healthcare company utilising AI-powered smartphone technology as part of a neurodevelopmental diagnostic approach, is pleased to announce that North Shore Pediatric Therapy (NSPT) has joined its US registrational study as the second clinical site. NSPT, a well-known provider … Continued
By API User
Sydney, Australia – 7 February 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) will host an investor webinar on Tuesday 11 February 2025. The webinar will be presented by OncoSil’s Chief Executive Officer & Managing Director, Nigel Lange, and will be followed by a short Q&A session. In his webinar presentation, Mr Lange … Continued
By API User
The webinar will be presented by AdAlta’s Chief Executive Officer & Managing Director, Dr Tim Oldham, and will be followed by a short Q&A session In his webinar presentation, Dr Oldham will discuss the results of AdAlta’s strategic review and portfolio prioritization announced separately today, including: • What drives AdAlta’s “East to West” cellular immunotherapy strategy• … Continued
By API User
5 February 2025 – Sydney, Australia | BlinkLab Limited (ASX: BB1) (“BlinkLab” or “the Company”), an innovative digital healthcare company leveraging AI-powered smartphone technology to transform autism and ADHD diagnostics, is pleased to announce the initiation of its first US-based clinical site for the autism diagnostic registrational trial. The PriMED Clinical Research LLC (“PriMED”) facility … Continued
By API User
With Northway Biotech’s expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and effective topical sCD83 treatment designed to stimulate hair follicle formation and promote sustained hair growth. ERLANGEN, GERMANY AND VILNIUS, LITHUANIA / ACCESS Newswire / February 4, 2025 / Mallia Therapeutics ("Mallia"), a biopharmaceutical company developing … Continued
By API User
Sydney, Australia – 04 February 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) (“OncoSil” or “the Company”) is pleased to announce that German Institute for the Hospital Remuneration System (InEK) has authorised 120 German hospitals to negotiate funding for the OncoSil™ device classification under the innovation funding (NUB) program with the statutory health insurance (SHI) … Continued
By API User
AdAlta Limited (ASX:1AD) (“AdAlta” or “the Company”), developer of next generation cell and protein therapeutic products is presenting at the 3rd ANZ Biologics Festival being held in Melbourne, Australia from 4-5 February, 2025. The 3rd ANZ Biologics Festival 2025 is the region’s premier conference that aims to gather the innovators, pioneers, and leaders in the … Continued
By API User
Highlights • Optiscan initiates pre-clinical GI study with University Medical Center Mainz, Germany • To support the study, Optiscan has completed its first prototype to collect images from the GI tract • The study will assess Optiscan’s Gen2 real-time imaging capability on GI tract tissue • Data from the study will be used to determine the utility of … Continued
